{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:29:32Z","timestamp":1786699772464,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2026,8,14]]},"DOI":"10.1038\/s41415-026-9804-6","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:39:48Z","timestamp":1786696788000},"page":"176-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral dysaesthesia associated with obinutuzumab \u2013 a case report"],"prefix":"10.1038","volume":"241","author":[{"given":"Annabelle","family":"Tibbett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"9804_CR4083","doi-asserted-by":"crossref","unstructured":"Farag M A, Carey B, Albuquerque R. Oral dysaesthesia: a special focus on aetiopathogenesis, clinical diagnostics and treatment modalities. Br Dent J 2024; 236: 275\u2013278.","DOI":"10.1038\/s41415-024-7057-9"},{"key":"9804_CR4085","doi-asserted-by":"crossref","unstructured":"Adamo D, Pecoraro G, Fortuna G et al. Assessment of oral health-related quality of life, measured by OHIP14 and GOHAI, and psychological profiling in burning mouth syndrome: a case-control clinical study. J Oral Rehabil 2020; 47: 42\u201352.","DOI":"10.1111\/joor.12864"},{"key":"9804_CR4088","unstructured":"International Headache Society. The International Classification of Headache Disorders, 3rd edition. Burning mouth syndrome. 2018. Available at https:\/\/ichd-3.org\/13-painful-cranial-neuropathies-and-other-facial-pains\/13-11-persistent-idiopathic-facial-pain-pifp\/ (accessed 16 July 2025)."},{"key":"9804_CR4091","unstructured":"British and Irish Society for Oral Medicine. Burning Mouth Syndrome (BMS) patient information leaflet. 2019. Available at https:\/\/bisom.org.uk\/wp-content\/uploads\/2020\/08\/BMS-PIL.pdf (accessed 17 February 2026)."},{"key":"9804_CR4094","doi-asserted-by":"crossref","unstructured":"Zakrzewska J, Buchanan J A. Burning mouth syndrome. BMJ Clin Evid 2006; DOI: 10.1159\/000101973","DOI":"10.1159\/000101973"},{"key":"9804_CR4096","doi-asserted-by":"crossref","unstructured":"Seixas R, Pessegueiro P. Management and diagnosis of empagliflozin-induced burning mouth syndrome: a case report. Cureus 2024; DOI: 10.7759\/cureus.70701.","DOI":"10.7759\/cureus.70701"},{"key":"9804_CR4099","unstructured":"Teruel A, Patel S. Burning mouth syndrome: a review of etiology, diagnosis, and management. Gen Dent 2019; 67: 24\u201329."},{"key":"9804_CR4101","doi-asserted-by":"crossref","unstructured":"Li X, Li N, Liu Y, An L. Unraveling the complexity of follicular lymphoma: insights and innovations. Am J Cancer Res 2024; 14: 5573\u20135597.","DOI":"10.62347\/MFUG2190"},{"key":"9804_CR4103","doi-asserted-by":"crossref","unstructured":"Sueira M S, Dantas J B de L, Martins G B, Leal D M S, Azevedo J S de J, Carrera M. Oral toxicities associated with immunotherapy and targeted therapy in cancer treatment. Oral Oncol Rep 2025; DOI: 10.1016\/j.oor.2025.100724.","DOI":"10.1016\/j.oor.2025.100724"},{"key":"9804_CR4105","doi-asserted-by":"crossref","unstructured":"Dabkowska A, Domka K, Firczuk M. Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells. Front Immunol 2024; DOI: 10.3389\/fimmu.2024.1363102.","DOI":"10.3389\/fimmu.2024.1363102"},{"key":"9804_CR4108","doi-asserted-by":"crossref","unstructured":"Davies A, Kater A P, Sharman J P et al. Obinutuzumab in the treatment of B cell malignancies: a comprehensive review. Future Oncol 2022; 18: 2943\u20132966.","DOI":"10.2217\/fon-2022-0112"},{"key":"9804_CR4110","doi-asserted-by":"crossref","unstructured":"Jacobsen E. Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol 2022; 97: 1638\u20131651.","DOI":"10.1002\/ajh.26737"},{"key":"9804_CR4112","doi-asserted-by":"crossref","unstructured":"Gholizadeh N, Sheykhbahaei N. Micronutrients status as a contributing factor in secondary burning mouth syndrome: a review of the literature. Health Sci Rep 2024; DOI: 10.1002\/hsr2.1906.","DOI":"10.1002\/hsr2.1906"},{"key":"9804_CR4114","unstructured":"National Institute for Health and Care Excellence. Rituximab: side-effects. Available at https:\/\/bnf.nice.org.uk\/drugs\/rituximab\/#side-effects (Accessed 24 September 2025)."},{"key":"9804_CR4117","doi-asserted-by":"crossref","unstructured":"Villa A, Kuten-Shorrer M. Pathogenesis of oral toxicities associated with targeted therapy and immunotherapy. Int J Mol Sci 2023; DOI: 10.3390\/ijms24098188.","DOI":"10.3390\/ijms24098188"},{"key":"9804_CR4119","doi-asserted-by":"crossref","unstructured":"Yuan A, Kurtz S L, Barysauskas C M, Pilotte A P, Wagner A J, Treister N S. Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors. Oral Oncol 2015; 51: 1026\u20131033.","DOI":"10.1016\/j.oraloncology.2015.09.003"},{"key":"9804_CR4122","doi-asserted-by":"crossref","unstructured":"Amitai I, Gafter-Gvili A, Shargian-Alon L et al. Obinutuzumab-related adverse events: a systematic review and meta-analysis. Hematol Oncol 2021; 39: 215\u2013221.","DOI":"10.1002\/hon.2828"},{"key":"9804_CR4124","unstructured":"National Institute for Health and Care Excellence. Obinutuzumab: specialist drug \u2013 side-effects. Available at  (accessed 20 July 2025)."},{"key":"9804_CR4126","unstructured":"Genentech. Gazyva prescribing information. Available at https:\/\/www.gene.com\/download\/pdf\/gazyva_prescribing.pdf (accessed 20 July 2025)."}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-026-9804-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-026-9804-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-026-9804-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:39:56Z","timestamp":1786696796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-026-9804-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,14]]}},"alternative-id":["9804"],"URL":"https:\/\/doi.org\/10.1038\/s41415-026-9804-6","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript has not been published or submitted for publication elsewhere. All authors involved have contributed significantly and are in agreement with the content and there is no conflict of interest. No patient identifiable information has been used within this manuscript, and the case report has been fully anonymised.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration Competing interests"}}]}}